Identification of A Potential Drug Target Or Biomarker: Rpl24p2

Target Name: RPL24P2

NCBI ID: G140760

RPL24P2

Other Name(s): dJ872K7.2 | RPL24 pseudogene 2 | RPL24_5_1691 | Ribosomal protein L24 pseudogene 2

Identification of A Potential Drug Target Or Biomarker: Rpl24p2

Rpl24p2 (dJ872K7.2) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. It is a member of the RNA-protein subfamily and is located in the chromosome 8 cluster D region. Rpl24p2 is highly conserved across various species, which suggests that it may have a conserved function. The function of Rpl24p2 is still not well understood, but it is known to play a role in various cellular processes, including cell growth, differentiation, and transcriptional regulation.

Drug Target Potential

Rpl24p2 is a potential drug target because of its unique structure and location on the genome. It is a small RNA molecule that is highly conserved across various species, which suggests that it may have a similar function in different organisms. Additionally, its location on the genome suggests that it may be involved in the regulation of gene expression. This is important because drugs that target specific RNA molecules have been shown to be effective in treating various diseases. For example, RNA interference technologies have been used to treat a variety of diseases , including cancer, HIV, and genetic disorders.

Biomarker Potential

Rpl24p2 may also be a useful biomarker for certain diseases. Its unique structure and function make it an attractive candidate for diagnostic tests. For example, Rpl24p2 has been shown to be downregulated in various diseases, including cancer, which suggests that it may be a useful biomarker for these diseases. Additionally, its expression has been shown to be regulated by various factors, including gene expression, DNA methylation, and histone modification. This suggests that Rpl24p2 may be a useful biomarker for studying the effects of drugs on gene expression and DNA methylation.

Function and Mechanism

The function of Rpl24p2 is not well understood, but its conserved structure and location on the genome suggest that it may be involved in the regulation of gene expression. Rpl24p2 is a small RNA molecule that is composed of 74 amino acid residues. It has a conserved structure, with a clear conserved domain and a conserved tail. The conserved domain is located at the C-terminus of the molecule and consists of the amino acids Asp-20, Asn-21, and Asp-22. The conserved tail is located at the N-terminus of the molecule and consists of the amino acids Asn-23, Asp-24, Asn-25, and Asp-26.

The function of Rpl24p2 is not well understood, but its conserved structure and location on the genome suggest that it may be involved in the regulation of gene expression. Rpl24p2 has been shown to play a role in the regulation of gene expression by controlling the levels of specific RNA molecules. For example, Rpl24p2 has been shown to act as a negative regulator of the expression of the gene encoding the protein ZNF2, which is involved in cell growth, survival, and angiogenesis.

Conclusion

Rpl24p2 is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and location on the genome suggest that it may be involved in the regulation of gene expression and the development of various diseases. Further research is needed to understand its function and mechanism.

Protein Name: RPL24 Pseudogene 2

The "RPL24P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL24P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets